LA Times: Researchers Sure to Find 'Lot to Like' in CIRM 2.0
The Los Angeles Times, the newspaper with the largest circulation in California, today took a crack at the California stem cell agency and its “reboot” as CIRM 2.0.
The piece was written by Michael Hiltzik, the Pulitzer Prize-winning columnist who has often been a critic of the $3 billion state research program. The springboard for the article was the r…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.